Practice Contact Information
8635 W. Third Street, Suite 590W
Web Site: http://bio.csmc.edu/view/14431/Allen-S-Ho.aspx
Areas of Interest in Head and Neck Surgery
Head and Neck Surgeon
Allen S. Ho, MD is a board-certified, fellowship-trained head and neck surgeon at Cedars-Sinai Medical Center. He focuses on the management of benign and malignant tumors of the head and neck.
Dr. Ho obtained his undergraduate degree at Harvard, completed his medical studies at UCLA, and underwent resident and fellowship training at Stanford and Memorial Sloan-Kettering Cancer Center, respectively. He is Clinical Director of the Head and Neck Cancer Center and leads the Head and Neck Tumor Board at the Oschin Comprehensive Cancer Institute within Cedars-Sinai.
Ho AS, Sarti ES, Wang H, Jain KS, Shaha AR, Shah JP, Tuttle RM, Ghossein R, Wong RJ, Lin O, Morris LG. Malignancy rate in thyroid nodules classified as atypia of undetermined significance [accepted in Thyroid].
Ho AS, Kannan K, Roy DM, Morris LG, Ganly I, Katabi N, Eng S, Turcan S, Ramaswami D, Shah JP, Singh B, Dolgalev I, Heguy A, Viale A, Drobnjak M, Leversha MA, Iyer NG, Leemans CR, Bloemena E, Ferris RL, Seethala RR, Schultz N, Sander C, Lee W, Chan TA. The mutational landscape of adenoid cystic carcinoma. Nature Genetics. 2013 July; 45(7):791-8.
Nixon IJ, Ho AS, Shah JP. Medullary cancer of the thyroid gland. Otorinolaringologia. 2013 June; 63(2):75-83.
Ho AS, Tsao GJ, Chen FW, Shen T, Kaplan MJ, Colevas AD, Fischbein NJ, Quon A, Le QT, Pinto HA, Fee WE Jr, Sunwoo JB, Sirjani D, Hara W, Yao M. Impact of PET/CT surveillance at 12 and 24 months for detecting head and neck cancer recurrence. Cancer. 2013 Apr 1; 119(7):1349-56.
Ho AS, Turcan S, Chan TA. Epigenetic therapy – use of deacetylases and demethylating agents in cancer management. OncoTargets and Therapy. 2013 Mar 20; 6:223-232.
Ho AS, Kraus DH, Ganly I, Lee NY, Shah JP, Morris LG. Decision-making in the management of recurrent head and neck cancer. Head and Neck. 2013 Mar 8; doi: 10.1002/hed.23227.
Agrawal N, Jiao Y, Sausen M, Leary R, Bettegowda C, Roberts NJ, Bhan S, Ho AS, Khan Z, Bishop J, Westra WH, Wood LD, Hruban RH, Tufano RP, Robinson B, Dralle H, Toledo SP, Toledo RA, Morris LG, Ghossein RA, Fagin JA, Chan TA, Velculescu VE, Vogelstein B, Kinzler KW, Papadopoulos N, Nelkin BD, Ball DW. Exomic sequencing of MTC reveals dominant and mutually exclusive oncogenic mutations in RET and RAS. J Clinical Endocrinology and Metabolism. 2013 Feb; 98(2):E364-9.
Damrose EJ, Ho AS. Endoscopic cricopharyngeal myotomy. Operative Techniques in OHNS. 2012 Jun; 23: 144-148.
Ho AS, Kaplan MJ, Fee WE, Yao M, Sunwoo JB, Hwang PH. Endoscopic salvage nasopharyngectomy for recurrent nasopharyngeal carcinoma. International Forum of Allergy and Rhinology. 2012 Mar; 2(2): 166-173.
Ho AS, Morzaria S, Damrose EJ. Management of intraoral needle migration into the posterior cervical space. Auris Nasus Larynx. 2011 Dec; 38(6): 747-9.
Barnes M*, Ho AS*, Malhotra PS, Koltai PJ, Messner AH. The use of botulinum toxin for pediatric cricopharyngeal achalasia. International Journal of Pediatric Otorhinolaryngology. 2011 Jun; 75(6): 830-4. [*co-first authors]
Ho AS, Morzaria S, Damrose EJ. Carbon dioxide laser-assisted endoscopic cricopharyngeal myotomy with primary mucosal closure. Annals of Otology, Rhinology, and Laryngology. 2011 Jan; 120(1): 33-39.
Ho AS, Huang X, Cao H, Christman-Skieller C, Le QT, Koong AC. Circulating miR-210 is a novel hypoxia marker in pancreatic cancer. Translational Oncology. 2010 Apr; 3(2): 109-13. [cover article]
Kassis JN, Virador VM, Guancial EA, Kimm D, Ho AS, Mishra M, Chuang EY, Cook J, Gius D, Kohn EC. Genomic and phenotypic analysis reveals a key role for CCN1 (Cyr61) in BAG-3 – modulated adhesion and invasion. Journal of Pathology. 2009 Aug; 218(4): 495-504.
Ho AS, Aleshi P, Cohen SE, Koltai PJ, Cheng AJ. Airway management in Nager Syndrome. International Journal of Pediatric Otorhinolaryngology. 2008 Dec; 72(12): 1885-1888.
Ho AS, Koltai PJ. Pediatric tracheal stenosis. Otolaryngologic Clinics of North America. 2008 Oct; 41(5): 999-1021.
Sun L, Huang L, Nguyen P, Bisht KS, Bar-Sela G, Ho AS, Bradbury CM, Yu W, Cui H, Lee S, Trepel JB, Feinberg AP, Gius D. DNA Methyltransferase 1 and 3B activate Bag-1 expression via recruitment of CTCFL/BORIS and modulation of promoter histone methylation. Cancer Research. 2008 Apt 15; 68(8): 2726-2735.
Mowry SE, Ho A, Lotempio MM, Sadeghi A, Blackwell KE, Wang MB. Quality of life in advanced oropharyngeal carcinoma following chemoradiation versus surgery and radiation. Laryngoscope. 2006 Sep; 116(9): 1589-1593.
Gius D, Bradbury CM, Sun L, Awwad RT, Huang L, Smart DD, Bisht KS, Ho AS, Nguyen P. The epigenome as a molecular marker and target. Cancer. 2005 Sep 7; 104(9): 1789-1793.
Gius D, Cui H, Bradbury CM, Cook J, Smart DK, Zhao S, Young L, Brandenburg SA, Hu Y, Bisht KS, Ho AS, Mattson D, Sun L, Munson PJ, Chuang EY, Mitchell JB, Feinberg AP. Distinct effects on gene expression of chemical and genetic manipulation of the cancer epigenome revealed by a multimodality approach. Cancer Cell. 2004 Oct; 6(4): 361-371.
Ho AS. Nicotine and caffeine as defensive agents against Parkinson Disease. Nutrition Bytes. 2002; Vol 8: No 2, Art 3.
Ho AS, Monuki E, Walsh CA. A potential genetic basis for schizencephaly. The Harvard Brain. 2001; Vol 8: 4-21.